Merlin Thomas

Merlin Thomas

Monash University

H-index: 85

Oceania-Australia

About Merlin Thomas

Merlin Thomas, With an exceptional h-index of 85 and a recent h-index of 48 (since 2020), a distinguished researcher at Monash University, specializes in the field of Diabetes.

His recent articles reflect a diverse array of research interests and contributions to the field:

Empagliflozin and Rapid Kidney Function Decline Incidence in Type 2 Diabetes: An Exploratory Analysis From the EMPA-REG OUTCOME Trial

Antisense oligomers for treatment of disease

Reduced methylation correlates with diabetic nephropathy risk in type 1 diabetes

Preventing progression of chronic kidney disease: Diet and lifestyle

The postprandial actions of GLP-1 receptor agonists: The missing link for cardiovascular and kidney protection in type 2 diabetes

Preventing progression of chronic kidney disease: renin–angiotensin–aldosterone system blockade beyond blood pressure

Pyridoxamine prevents increased atherosclerosis by intermittent methylglyoxal spikes in the aortic arches of ApoE-/-mice

SARS-CoV-2 mouse adaptation selects virulence mutations that cause TNF-driven age-dependent severe disease with human correlates

Merlin Thomas Information

University

Position

Professor Department of Diabetes

Citations(all)

25985

Citations(since 2020)

9425

Cited By

20269

hIndex(all)

85

hIndex(since 2020)

48

i10Index(all)

235

i10Index(since 2020)

160

Email

University Profile Page

Monash University

Google Scholar

View Google Scholar Profile

Merlin Thomas Skills & Research Interests

Diabetes

Top articles of Merlin Thomas

Title

Journal

Author(s)

Publication Date

Empagliflozin and Rapid Kidney Function Decline Incidence in Type 2 Diabetes: An Exploratory Analysis From the EMPA-REG OUTCOME Trial

Kidney Medicine

Samy Hadjadj

Mark E Cooper

Dominik Steubl

Michaela Petrini

Stefan Hantel

...

2024/3/1

Antisense oligomers for treatment of disease

2023/12/21

Reduced methylation correlates with diabetic nephropathy risk in type 1 diabetes

The Journal of Clinical Investigation

Ishant Khurana

Harikrishnan Kaipananickal

Scott Maxwell

Sørine Birkelund

Anna Syreeni

...

2023/2/15

Preventing progression of chronic kidney disease: Diet and lifestyle

Merlin C Thomas

2023/11/25

The postprandial actions of GLP-1 receptor agonists: The missing link for cardiovascular and kidney protection in type 2 diabetes

Merlin C Thomas

Melinda T Coughlan

Mark E Cooper

2023/2/7

Preventing progression of chronic kidney disease: renin–angiotensin–aldosterone system blockade beyond blood pressure

Merlin C Thomas

2023/11/25

Pyridoxamine prevents increased atherosclerosis by intermittent methylglyoxal spikes in the aortic arches of ApoE-/-mice

Biomedicine & Pharmacotherapy

Nordin MJ Hanssen

Chris Tikellis

Raelene J Pickering

Dragana Dragoljevic

Man Kit Sam Lee

...

2023/2/1

SARS-CoV-2 mouse adaptation selects virulence mutations that cause TNF-driven age-dependent severe disease with human correlates

Proceedings of the National Academy of Sciences

Stefanie M Bader

James P Cooney

Dylan Sheerin

George Taiaroa

Leigh Harty

...

2023/8/8

SGLT2 inhibitors for patients with type 2 diabetes and CKD: a narrative review

Merlin C Thomas

Brendon L Neuen

Stephen M Twigg

Mark E Cooper

Sunil V Badve

2023/7/31

Modulators and modulation of the receptor for advanced glycation end-products RNA

2023/6/13

Circulating Soluble ACE2 Plays an Independent Role to Protect against Vascular Damage in Diabetic Mice

Antioxidants

Chris Tikellis

Gardner N Robinson

Carlos J Rosado

Duygu Batu

Maria A Zuniga-Gutierrez

...

2022/5/18

The clustering of cardiovascular, renal, adipo-metabolic eye and liver disease with type 2 diabetes

MC Thomas

2022/3/1

Analysis of serum advanced glycation endproducts reveals methylglyoxal-derived advanced glycation MG-H1 free adduct is a risk marker in non-diabetic and diabetic chronic kidney …

International Journal of Molecular Sciences

Naila Rabbani

Antonysunil Adaikalakoteswari

James R Larkin

Sianna Panagiotopoulos

Richard J MacIsaac

...

2022/12/21

Screening Assays, Modulators and Modulation of Intracellular Signalling Mediated by Immunoglobulin Superfamily Cell Adhesion Molecules

2022/6/2

SCREENING TESTS, MODULATORS AND MODULATION OF THE ACTIVATION OF A RECEIVER FOR TERMINAL PRODUCTS OF ADVANCED GLYCATION (RAGE)

2021/6/9

Dietary intake and hospitalisation due to diabetic ketoacidosis and hypoglycaemia in individuals with type 1 diabetes

Scientific Reports

Aila J Ahola

Valma Harjutsalo

Merlin C Thomas

Carol Forsblom

Per-Henrik Groop

2021/1/15

Severe acute respiratory syndrome coronavirus 2 as a potential cause of type 1 diabetes facilitated by spike protein receptor binding domain attachment to human islet cells: An …

Diabetic Medicine

Nisha Venkatesh

Natalie Astbury

Merlin C Thomas

Carlos J Rosado

Evan Pappas

...

2021/11

Common comorbidities that alter heart failure prognosis-shaping new thinking for practice

Pupalan Iyngkaran

Merlin Thomas

John D Horowitz

Paul Komesaroff

Michael Jelinek

...

2021/10/10

Targeting the pathobiology of diabetic kidney disease

Merlin C Thomas

2021/7/1

A physician-initiated double-blind, randomised, placebo-controlled, phase 2 study evaluating the efficacy and safety of inhibition of NADPH oxidase with the first-in-class Nox …

Contemporary clinical trials

Anne T Reutens

Karin Jandeleit-Dahm

Merlin Thomas

Agus Salim

Alysha M De Livera

...

2020/3/1

See List of Professors in Merlin Thomas University(Monash University)